Biology of Blood and Marrow Transplantation
Volume 11, Issue 11 , Pages 890-902 , November 2005

Cytomegalovirus Immune Reconstitution Occurs in Recipients of Allogeneic Hematopoietic Cell Transplants Irrespective of Detectable Cytomegalovirus Infection

  • Ghislaine Gallez-Hawkins

      Affiliations

    • Division of Virology, Beckman Research Institute, City of Hope National Medical Center, Duarte, California, USA
    • ,
  • Lia Thao

      Affiliations

    • Division of Virology, Beckman Research Institute, City of Hope National Medical Center, Duarte, California, USA
    • ,
  • Simon F. Lacey

      Affiliations

    • Laboratory of Vaccine Research, Beckman Research Institute, City of Hope National Medical Center, Duarte, California, USA
    • ,
  • Joybelle Martinez

      Affiliations

    • Laboratory of Vaccine Research, Beckman Research Institute, City of Hope National Medical Center, Duarte, California, USA
    • ,
  • Xiuli Li

      Affiliations

    • Division of Virology, Beckman Research Institute, City of Hope National Medical Center, Duarte, California, USA
    • ,
  • Anne E. Franck

      Affiliations

    • Division of Virology, Beckman Research Institute, City of Hope National Medical Center, Duarte, California, USA
    • ,
  • Norma A. Lomeli

      Affiliations

    • Division of Information Sciences, Beckman Research Institute, City of Hope National Medical Center, Duarte, California, USA
    • ,
  • Jeff Longmate

      Affiliations

    • Division of Information Sciences, Beckman Research Institute, City of Hope National Medical Center, Duarte, California, USA
    • ,
  • Don J. Diamond

      Affiliations

    • Laboratory of Vaccine Research, Beckman Research Institute, City of Hope National Medical Center, Duarte, California, USA
    • ,
  • Ricardo Spielberger

      Affiliations

    • Department of Hematology and Bone Marrow Transplantation, City of Hope National Medical Center, Duarte, California, USA
    • ,
  • Stephen J. Forman

      Affiliations

    • Department of Hematology and Bone Marrow Transplantation, City of Hope National Medical Center, Duarte, California, USA
    • ,
  • John A. Zaia

      Affiliations

    • Division of Virology, Beckman Research Institute, City of Hope National Medical Center, Duarte, California, USA
    • Corresponding Author InformationCorrespondence and reprint requests: John A. Zaia, MD, Beckman Research Institute of the City of Hope, Division of Virology, 1500 E. Duarte Rd., Duarte, CA 91010

Received 6 June 2005 ,Accepted 13 July 2005.

References 

  1. Lacey SF , Diamond DJ , Zaia JA . Assessment of cellular immunity to human cytomegalovirus in recipients of allogeneic stem cell transplants . Biol Blood Marrow Transplant . 2004;10:433–447
  2. Elkington R , Walker S , Crough T , et al.   Ex vivo profiling of CD8+-T-cell responses to human cytomegalovirus reveals broad and multispecific reactivities in healthy virus carriers . J Virol . 2003;77:5226–5240
  3. Greenberg PD , Reusser P , Goodrich JM , Riddell SR . Development of a treatment regimen for human cytomegalovirus (CMV) infection in bone marrow transplantation recipients by adoptive transfer of donor-derived CMV-specific T cell clones expanded in vitro . Ann N Y Acad Sci . 1991;636:184–195
  4. Wills MR , Carmichael AJ , Mynard K , et al.   The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65 (frequency, specificity, and T-cell receptor usage of pp65-specific CTL) . J Virol . 1996;70:7569–7579
  5. Diamond DJ , York J , Sun JY , Wright CL , Forman SJ . Development of a candidate HLA A*0201 restricted peptide-based vaccine against human cytomegalovirus infection . Blood . 1997;90:1751–1767
  6. Solache A , Morgan CL , Dodi AI , et al.   Identification of three HLA-A*0201-restricted cytotoxic T cell epitopes in the cytomegalovirus protein pp65 that are conserved between eight strains of the virus . J Immunol . 1999;163:5512–5518
  7. Engstrand M , Lidehall AK , Totterman TH , Herrman B , Eriksson BM , Korsgren O . Cellular responses to cytomegalovirus in immunosuppressed patients (circulating CD8+ T cells recognizing CMVpp65 are present but display functional impairment) . Clin Exp Immunol . 2003;132:96–104
  8. Lacey SF , Gallez-Hawkins G , Crooks M , et al.   Characterization of cytotoxic function of CMV-pp65-specific CD8+ T-lymphocytes identified by HLA tetramers in recipients and donors of stem-cell transplants . Transplantation . 2002;74:722–732
  9. Mohty M , Mohty AM , Blaise D , et al.   Cytomegalovirus-specific immune recovery following allogeneic HLA-identical sibling transplantation with reduced-intensity preparative regimen . Bone Marrow Transplant . 2004;33:839–846
  10. Gallez-Hawkins G , Lomeli NA , Li X , et al.   Kinase-deficient CMVpp65 triggers a CMVpp65 specific T-cell immune response in HLA-A*0201.Kb transgenic mice after DNA immunization . Scand J Immunol . 2002;55:592–598
  11. Aubert G , Hassan-Walker AF , Madrigal JA , et al.   Cytomegalovirus-specific cellular immune responses and viremia in recipients of allogeneic stem cell transplants . J Infect Dis . 2001;184:955–963
  12. Chen FE , Aubert G , Travers P , Dodi IA , Madrigal JA . HLA tetramers and anti-CMV immune responses (from epitope to immunotherapy) . Cytotherapy . 2002;4:41–48
  13. Engstrand M , Tournay C , Peyrat MA , et al.   Characterization of CMVpp65-specific CD8+ T lymphocytes using MHC tetramers in kidney transplant patients and healthy participants . Transplantation . 2000;69:2243–2250
  14. Gratama JW , van Esser JW , Lamers CH , et al.   Tetramer-based quantification of cytomegalovirus (CMV)-specific CD8+ T lymphocytes in T-cell-depleted stem cell grafts and after transplantation may identify patients at risk for progressive CMV infection . Blood . 2001;98:1358–1364
  15. Cwynarski K , Ainsworth J , Cobbold M , et al.   Direct visualization of cytomegalovirus-specific T-cell reconstitution after allogeneic stem cell transplantation . Blood . 2001;97:1232–1240
  16. Manley TJ , Luy L , Jones T , Boeckh M , Mutimer H , Riddell SR . Immune evasion proteins of human cytomegalovirus do not prevent a diverse CD8+ cytotoxic T-cell response in natural infection . Blood . 2004;104:1075–1082
  17. Bunde T , Kirchner A , Hoffmeister B , et al.   Protection from cytomegalovirus after transplantation is correlated with immediate early 1-specific CD8 T cells . J Exp Med . 2005;201:1031–1036
  18. Khan N , Cobbold M , Keenan R , Moss PA . Comparative analysis of CD8+ T cell responses against human cytomegalovirus proteins pp65 and immediate early 1 shows similarities in precursor frequency, oligoclonality, and phenotype . J Infect Dis . 2002;185:1025–1034
  19. Prod’homme V , Retiere C , Imbert-Marcille BM , Bonneville M , Hallet MM . Modulation of HLA-A*0201-restricted T cell responses by natural polymorphism in the IE1(315-324) epitope of human cytomegalovirus . J Immunol . 2003;170:2030–2036
  20. Retiere C , Prod’homme V , Imbert-Marcille BM , Bonneville M , Vie H , Hallet MM . Generation of cytomegalovirus-specific human T-lymphocyte clones by using autologous B-lymphoblastoid cells with stable expression of pp65 or IE1 proteins (a tool to study the fine specificity of the antiviral response) . J Virol . 2000;74:3948–3952
  21. Frankenberg N , Pepperl-Klindworth S , Meyer RG , Plachter B . Identification of a conserved HLA-A2-restricted decapeptide from the IE1 protein (pUL123) of human cytomegalovirus . Virology . 2002;295:208–216
  22. Gibson L , Piccinini G , Lilleri D , et al.   Human cytomegalovirus proteins pp65 and immediate early protein 1 are common targets for CD8+ T cell responses in children with congenital or postnatal human cytomegalovirus infection . J Immunol . 2004;172:2256–2264
  23. Gallez-Hawkins G , Villacres MC , Li X , Sanborn MC , Lomeli NA , Zaia JA . Use of transgenic HLA A*0201/Kb and HHD II mice to evaluate frequency of cytomegalovirus IE1-derived peptide usage in eliciting human CD8 cytokine response . J Virol . 2003;77:4457–4462
  24. Zaia JA , Schmidt GM , Chao NJ , et al.   Preemptive ganciclovir administration based solely on asymptomatic pulmonary cytomegalovirus infection in allogeneic bone marrow transplant recipients (long-term follow-up) . Biol Blood Marrow Transplant . 1995;1:88–93
  25. Bensinger WI , Martin PJ , Storer B , et al.   Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers . N Engl J Med . 2001;344:175–181
  26. Limaye AP , Huang ML , Leisenring W , Stensland L , Corey L , Boeckh M . Cytomegalovirus (CMV) DNA load in plasma for the diagnosis of CMV disease before engraftment in hematopoietic stem-cell transplant recipients . J Infect Dis . 2001;183:377–382
  27. Dunn HS , Haney DJ , Ghanekar SA , Stepick-Biek P , Lewis DB , Maecker HT . Dynamics of CD4 and CD8 T cell responses to cytomegalovirus in healthy human donors . J Infect Dis . 2002;186:15–22
  28. Heijnen IA , Barnett D , Arroz MJ , et al.   Enumeration of antigen-specific CD8+ T lymphocytes by single-platform, HLA tetramer-based flow cytometry (a European multicenter evaluation) . Cytometry B Clin Cytom . 2004;62:1–13
  29. Hebart H , Rauser G , Stevanovic S , et al.   A CTL epitope from human cytomegalovirus IE1 defined by combining prediction of HLA binding and proteasomal processing is the target of dominant immune responses in patients after allogeneic stem cell transplantation . Exp Hematol . 2003;31:966–973
  30. Komatsu H , Sierro S , Cuero A , Klenerman P . Population analysis of antiviral T cell responses using MHC class I-peptide tetramers . Clin Exp Immunol . 2003;134:9–12
  31. Villacres MC , Lacey SF , Auge C , Longmate J , Leedom JM , Diamond DJ . Relevance of peptide avidity to the T cell receptor for cytomegalovirus-specific ex vivo CD8 T cell cytotoxicity . J Infect Dis . 2003;188:908–918
  32. Ouyang Q , Wagner WM , Wikby A , et al.   Large numbers of dysfunctional CD8+ T lymphocytes bearing receptors for a single dominant CMV epitope in the very old . J Clin Immunol . 2003;23:247–257
  33. Gratama J , Cornelissen J . Clinical utility of tetramer-based immune monitoring in allogeneic stem cell transplantation . BioDrugs . 2003;17:325–338
  34. La Rosa C , Wang Z , Brewer JC , et al.   Preclinical development of an adjuvant-free peptide vaccine with activity against CMV pp65 in HLA transgenic mice . Blood . 2002;100:3681–3689
  35. Foster AE , Gottlieb DJ , Sartor M , Hertzberg MS , Bradstock KF . Cytomegalovirus-specific CD4+ and CD8+ T-cells follow a similar reconstitution pattern after allogeneic stem cell transplantation . Biol Blood Marrow Transplant . 2002;8:501–511
  36. Villacres MC , Lacey SF , La Rosa C , et al.   Human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy maintain activated CD8+ T cell subsets as a strong adaptive immune response to cytomegalovirus . J Infect Dis . 2001;184:256–2671
  37. He XS , Rehermann B , Boisvert J , et al.   Direct functional analysis of epitope-specific CD8+ T cells in peripheral blood . Viral Immunol . 2001;14:59–69
  38. Szmania S , Galloway A , Bruorton M , et al.   Isolation and expansion of cytomegalovirus-specific cytotoxic T lymphocytes to clinical scale from a single blood draw using dendritic cells and HLA-tetramers . Blood . 2001;98:505–512
  39. Gandhi MK , Wills MR , Okecha G , et al.   Late diversification in the clonal composition of human cytomegalovirus-specific CD8+ T cells following allogeneic hemopoietic stem cell transplantation . Blood . 2003;102:3427–3438

PII: S1083-8791(05)00463-5

doi: 10.1016/j.bbmt.2005.07.008

Biology of Blood and Marrow Transplantation
Volume 11, Issue 11 , Pages 890-902 , November 2005

Article Tools

* Image Usage & Resolution